Lipoic Acid For Treating Multiple Sclerosis

Dennis-Bourdette-Paris-Redox-2019Dr. Dennis Bourdette is Chair, the Roy and Eulalia Swank Family Research Professor and Executive Director of the Multiple Sclerosis Center in the Department of Neurology at Oregon Health & Science University, Portland OR, USA.  Dr. Bourdette conducts research seeking to develop new therapeutics for multiple sclerosis (MS) and has published over 200 articles on investigations related to MS. He will join the Paris Redox congress, which will be held on June 20-21 2019, to present us his study entitled "Lipoic Acid For Treating Multiple Sclerosis".

For more information about Paris Redox 2019: